Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies
Conferences
O'Donovan, B; Rittiner, J; Kantor, B; Chiba-Falek, O
Published in: MOLECULAR THERAPY
April 28, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Donovan, B., Rittiner, J., Kantor, B., & Chiba-Falek, O. (2025). Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies. In MOLECULAR THERAPY (Vol. 33).
O’Donovan, Bernadette, Joseph Rittiner, Boris Kantor, and Ornit Chiba-Falek. “Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies.” In MOLECULAR THERAPY, Vol. 33, 2025.
O’Donovan B, Rittiner J, Kantor B, Chiba-Falek O. Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies. In: MOLECULAR THERAPY. 2025.
O’Donovan, Bernadette, et al. “Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies.” MOLECULAR THERAPY, vol. 33, no. 4, 2025.
O’Donovan B, Rittiner J, Kantor B, Chiba-Falek O. Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies. MOLECULAR THERAPY. 2025.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics